Smith & Nephew (NYSE:SNN) Stock Rating Lowered by Berenberg Bank

Smith & Nephew (NYSE:SNN) was downgraded by investment analysts at Berenberg Bank from a “buy” rating to a “hold” rating in a report issued on Wednesday, Marketbeat Ratings reports.

SNN has been the subject of a number of other research reports. Deutsche Bank Aktiengesellschaft cut Smith & Nephew from a “buy” rating to a “hold” rating in a research report on Friday, November 1st. StockNews.com upgraded Smith & Nephew from a “buy” rating to a “strong-buy” rating in a research note on Monday, August 5th. Three investment analysts have rated the stock with a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy”.

Smith & Nephew Stock Up 1.0 %

Shares of NYSE:SNN opened at $24.72 on Wednesday. The business’s 50-day moving average is $29.62 and its 200 day moving average is $27.84. The company has a quick ratio of 1.11, a current ratio of 2.51 and a debt-to-equity ratio of 0.63. Smith & Nephew has a 1 year low of $23.65 and a 1 year high of $31.72.

Institutional Trading of Smith & Nephew

A number of institutional investors and hedge funds have recently modified their holdings of SNN. Mather Group LLC. raised its stake in Smith & Nephew by 9,735.3% in the 2nd quarter. Mather Group LLC. now owns 1,672 shares of the medical equipment provider’s stock valued at $42,000 after purchasing an additional 1,655 shares during the last quarter. Allspring Global Investments Holdings LLC grew its holdings in shares of Smith & Nephew by 1,894.3% during the second quarter. Allspring Global Investments Holdings LLC now owns 1,735 shares of the medical equipment provider’s stock worth $43,000 after buying an additional 1,648 shares in the last quarter. EverSource Wealth Advisors LLC grew its holdings in shares of Smith & Nephew by 92.5% during the second quarter. EverSource Wealth Advisors LLC now owns 2,454 shares of the medical equipment provider’s stock worth $61,000 after buying an additional 1,179 shares in the last quarter. GAMMA Investing LLC raised its position in shares of Smith & Nephew by 160.0% in the third quarter. GAMMA Investing LLC now owns 2,257 shares of the medical equipment provider’s stock valued at $70,000 after buying an additional 1,389 shares during the last quarter. Finally, Headlands Technologies LLC lifted its stake in shares of Smith & Nephew by 225.0% in the first quarter. Headlands Technologies LLC now owns 3,851 shares of the medical equipment provider’s stock worth $98,000 after buying an additional 2,666 shares in the last quarter. Hedge funds and other institutional investors own 25.64% of the company’s stock.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.